Search Within

CTCR Scholars

  1. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
Formats
  1. Meeting Abstract (29)
  2. Journal Article (26)
  3. Editorial (3)
  4. Review (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (60)
  2. Department of Medicine (59)
  3. Hematology-Oncology Fellows (58)
  4. GSK Faculty (57)
  5. Solid Tumor Oncology Division (57)
  6. Human Oncology and Pathogenesis Program (43)

More Groups

People
  1. Pedram Razavi (26)
  2. Bob Li (22)
  3. Sarat Chandarlapaty (21)
  4. Charles Rudin (20)
  5. Joshua Drago (18)
  6. Jorge Reis-Filho (17)

More People

Years
  1. 2025 (9)
  2. 2024 (12)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (7)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Cancer Research (8)
  3. Cancer Discovery (4)
  4. Clinical Cancer Research (4)
  5. Blood (3)
  6. Nature (3)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (15)
  3. Nature Publishing Group (11)
  4. Oxford University Press (5)
  5. Elsevier Inc. (4)
  6. American Society of Hematology (3)

More Publishers

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antibody drug conjugates in metastatic brain tumors: current landscape, therapeutic potential and challenges
    Review

    Robert, S. M.; Toth, A.; Lev, S.; Bowden, S. G.; Yu, Y.; Imber, B. S.; Boire, A.; Drago, J. Z.; Modi, S.; Moss, N. S.
    Journal of Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • Genomic predictors of brain metastases in breast cancer
    Meeting Abstract

    Safonov, A.; Smith, D. R.; Nandakumar, S.; Ferraro, E.; Shen, J.; Khatri, I. S.; Kumar, R.; An, J. A. R.; Jee, J.; Robson, M. E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of ERBB2 activating mutations on enhanced internalization and activity of trastuzumab deruxtecan in HER2-non-amplified metastatic breast cancer
    Meeting Abstract

    Mai, N.; Liu, B.; Safonov, A.; Shen, S.; Zelizer, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.; Modi, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Sequential antibody-drug conjugate therapy in patients with metastatic breast cancer treated with sacituzumab govitecan and trastuzumab deruxtecan
    Journal Article

    Mai, N.; Lieberman, M. M. K.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
    Journal Article

    Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia
    Journal Article

    Millman, S. E.; Chaves-Perez, A.; Janaki-Raman, S.; Ho, Y. J.; Morris, J. P. 4th; Narendra, V.; Chen, C. C.; Jackson, B. T.; Yashinskie, J. J.; Mezzadra, R.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Multimodal histopathologic models stratify hormone receptor-positive early breast cancer
    Journal Article

    Boehm, K. M.; El Nahhas, O. S. M.; Marra, A.; Waters, M.; Jee, J.; Braunstein, L.; Schultz, N.; Selenica, P.; Wen, H. Y.; Weigelt, B.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Progressive plasticity during colorectal cancer metastasis
    Journal Article

    Moorman, A. R.; Benitez, E. K.; Cambuli, F.; Jiang, Q.; Mahmoud, A.; Lumish, M.; Hartner, S.; Balkaran, S.; Bermeo, J.; Asawa, S.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save